Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

REGN

23 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in Regeneron Pharmaceuticals, Inc.

No. Polar Capital Holdings exited its REGN (Regeneron Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 192,546 shares worth $148.8M. Polar Capital Holdings already held REGN in its Q4 2020 13F, the earliest on record, and held it in 22 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$45.9M

Total Shares Change

-95,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$622.81
0
2026-Q1
Decreased
192,546
-6.0%
$148.8M0.5%$770.59
0
2025-Q4
Increased
204,927
+29.0%
$158.2M0.6%$768.90
54
2025-Q3
Increased
158,817
+126.9%
$89.3M0.4%$559.40
58
2025-Q2
Increased
70,000
+27.3%
$36.8M0.2%$521.53
43
2025-Q1
Decreased
55,000
-2.2%
$34.9M0.2%$629.11
0
2024-Q4
Decreased
56,249
-21.6%
$40.1M0.2%$705.67
0
2024-Q3
Decreased
71,795
-46.0%
$75.5M0.4%$1,041.41
0
2024-Q2
Decreased
133,031
-24.8%
$139.8M0.8%$1,041.20
0
2024-Q1
Decreased
176,958
-10.6%
$170.3M0.9%$953.49
0
2023-Q4
Increased
197,847
+49.3%
$173.8M1.1%$870.08
66
2023-Q3
Unchanged
132,500
0.0%
$109M0.8%$815.27
0
2023-Q2
Unchanged
132,500
0.0%
$95.2M0.5%$711.82
0
2023-Q1
Increased
132,500
+12.8%
$108.9M0.7%$813.99
48
2022-Q4
Increased
117,500
+4.4%
$84.8M0.7%$714.75
44
2022-Q3
Decreased
112,500
-10.0%
$77.5M0.5%$682.43
0
2022-Q2
Decreased
125,000
-13.8%
$73.9M0.4%$585.60
0
2022-Q1
Decreased
145,000
-14.7%
$101.3M0.5%$691.89
0
2021-Q4
Unchanged
170,000
0.0%
$107.4M0.4%$625.62
0
2021-Q3
Increased
170,000
+13.3%
$102.9M0.4%$599.52
41
2021-Q2
Increased
150,000
+100.0%
$83.8M0.4%$553.32
57
2021-Q1
Decreased
75,000
-21.1%
$35.5M0.2%$468.72
0
2020-Q4
First report
95,000
-
$45.9M0.3%$478.59
0

Other major holders of REGN: FMR LLC, Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used